Anavex Life Sciences Corp (AVXL)

[biotechnician]

Will this be our buyer?

Takeda, a Japanese drug company, is prepared to spend as much as $15 billion for possible acquisitions in an effort to increase its business in the U.S., the Financial Times reports, citing sources.

The drug maker has told investors it would like to purchase U.S. companies developing drugs for cancer, gastrointestinal conditions and central nervous system diseases, such as Alzheimer's, according to the sources.